A simple and selective HPLC-fluorescence (FL) method with FL probe, 2 4-[4-(4-dimethylaminophenyl)-5-phenyl-1H-imidazol-2-yl]benzoic acid methyl ester (DAPIM), for 3 simultaneous determination of mercaptalbumin (HMA) and nonmercaptalbumin (HNA1) was 4 developed. After HMA and HNA1 were separated on an ion-exchange column, they were on-line 5 and post-column mixed with DAPIM. The DAPIM-albumin complex produces FL (λex 370 nm 6 and λem 510 nm); however, DAPIM solution never gives the FL. Based on this mechanism, 7 selective determination of HMA and HNA1 were achieved without any pretreatment and interfering 8 peak. The proposed method was applied to the measurement of HMA and HNA1 in human serum 9 of healthy volunteers and diabetes mellitus patients. 10 11 Keywords: 4-[4-(4-dimethylaminophenyl)-5-phenyl-1H-imidazol-2-yl]benzoic acid methyl ester; 12 fluorescence probe; mercaptalbumin; nonmercaptalbumin; redox state 13 14
Introduction
Human serum albumin (HSA) is composed of mercaptalbumin (HMA) with a free thiol group 2 on Cys-34, nonmercaptalbumin 1 (HNA1) with Cys-34 bound to cystein or glutathione by a 3 disulfide bond, and nonmercaptalbumin 2 (very small amount) with Cys-34 oxidized to sulfenic, 4 sulfinic or sulfonic [1] [2] [3] [4] . HMA is the major extracellular source of reduced sulfhydryl groups, 5 which are potent scavengers of reactive oxygen and nitrogen species [8] . It is known that HMA is 6 reversibly converted to HNA1 accompanied with increasing of oxidative stress by reactive oxygen 7 and nitrogen species. Oxidative stress is believed to play a major role in the pathogenesis of 8 several diseases [5] [6] [7] . Therefore, in order to observe the redox state of circulatory system, HMA 9 and HNA were extensively determined in serum or other biological fluids of the elderly and the 10 patients with renal and liver dysfunctions, endocrine diseases, eye diseases [1, [9] [10] [11] [12] [13] [14] [15] [16] . 11 Several HPLC methods with ultraviolet (UV) or fluorescence (FL) detection were developed 12 for the determination of HMA and HNA1 [9, 10, 13-17]. Because of many interfering peaks 13 observed by UV detection, most of them were based on FL detection using the native FL of 14 tryptophan residue in HSA. The use of native FL would be ideal but it still suffers from interfering 15 substances from biological extracts [18]; indeed, large peaks except for HMA and HNA1 were 16 found in chromatograms obtained by above HPLC-FL methods [14, 15, 17] . In this article, 17 HPLC-FL method using an FL probe specifically binding to HSA must be a useful technique for 18 selective and sensitive determination of HMA and HNA1; however, such a method has yet to be 19 developed. 20 Previously, we discovered that a lophine derivative, 4-[4-(4-dimethylaminophenyl)-21 5-phenyl-1H-imidazol-2-yl]benzoic acid methyl ester (DAPIM, Fig. 1 ) has almost no fluorescence, 22 but the fluorescence intensity of DAPIM solution was drastically enhanced by the addition of HSA 1 [19] , which was a result of the interaction between DAPIM and HSA. Furthermore, we revealed 2 that DAPIM specifically binds to the site II in subdomain IIIA of HSA with higher binding constant 3 than other FL probes and is successfully applied for fluorometric measurement of total albumin in 4 human serum [20] . 5 The aim of this study is developing a highly selective HPLC-FL method using DAPIM for 6 simultaneous determination of HMA and HNA, and applying it for human serum samples of healthy 7 volunteers and diabetes mellitus (DM). Oxidation of HSA 10 Usually, HSA is commercially available as a mixture of HMA and HNA1. In order to 11 identify peaks on a chromatogram, HMA in commercially available HSA was forcibly oxidized to 12 HNA1 by the incubation with L-cystine. HSA (50 mg) was dissolved in 1.25 mL L-cystine 13 solution (2 mM in phosphate buffer (pH 6.87)) and mixed by shaking at 20 °C for 3 h. Then, the 14 mixture was filtered and incubated at 35 °C for 108 h. School of Biomedical Sciences, Nagasaki University. Whole blood was collected into glass tubes 20 containing coagulation accelerator. The coagulated blood is left to clot at room temperature for 30 21 min. After removing the clot by centrifugation at 1300 x g for 10 min at 4 °C, the resulting 22 6 supernatant (serum) was stored at -35 °C. Serum samples were 20-fold diluted with phosphate 1 buffered saline, and then were injected into the HPLC system. incubation with L-cystine, respectively. Two major peaks were detected at 13 and 23 min on the 7 chromatogram before the reaction with L-cystine. After the reaction, the peak at 13 min was 8 disappeared while the peak at 23 min increased. These results indicated that the component of the 9 peak at 13 min was converted to the component of the peak at 23 min by the oxidation with 10 L-cystine. Therefore, the peaks at 13 and 23 min could be identified to HMA and HNA1, 11 respectively. 12 In order to make the analytical performance better, the analytical conditions including the pH 13 and concentration of buffer as well as the concentration of DAPIM in the post-column 14 derivatization reagent solution were optimized using HSA standard solution. 15 In previous study, it was found that higher pH provided stronger fluorescence of DAPIM 16 binding to HSA [20] . Based on this finding, the effect of pH of borate buffer in post-column 17 derivatization reagent was studied, ranging from 9.3 to 10.7. As the pH increases, the peak area of 18 HMA and HNA1 increased. Different concentrations of borate buffer ranging from 20 to 120 mM 19 were studied. Maximum and constant peak area could be obtained at 70 mM or more; 70 mM was 20 selected for subsequent work. Subsequently, DAPIM concentration was examined over the range 21 of 1 to 5 µM in 70 mM borate buffer (pH 10.7) (Fig. 4) . The peak area increased as DAPIM 22 concentration increased and the highest and constant peak area was provided at concentration 1 higher than 4 µM; 4 µM was chosen as an optimum. The precision and accuracy of the method were determined by using healthy serum samples. 5 Precision (%) is expressed as relative standard deviation (RSD). During the course of method 6 validation, intra-and inter-day precision were 1.9% and 4.0% for HMA and 4.3% and 7.5% for 7 HNA1. These data show that the method has sufficient reproducibility in human serum analysis. 8 As reported in our previous study [20] , site II-binding drugs such as diazepam can competitively 9 bind to HSA against DAPIM, resulting in underestimation. However, such underestimation occurs 10 only when the concentration of diazepam is 4-fold higher than its therapeutic concentration. Also, 11 site-II binding drug should equally bind with HMA and HNA1; therefore, the ratio of HMA and 12 HNA1 is not affected. (Fig. 3 D) , there were no any 17 peak around the peaks of HMA and HNA1. This advantage in our proposed method can realize 18 highly selective analysis of HMA and HNA1. In the same way, peaks of HMA and HNA1 in 19 serum of DM patients could be clearly detected without any interference from other biological 20 components ( Fig. 3 E) . Also, similarly as previous study [9] , the concentration of HNA1 in serum 21 was smaller than that of HMA. The values of f(HMA) and f(HNA1) were calculated by measurement of HMA and HNA1 are 1 summarized in Table 1 . In this study, age-and sex-matched healthy volunteers could not be We developed a selective method for the simultaneous determination of HMA and HNA1 by 13 HPLC-FL using DAPIM as an FL probe. Because DAPIM specifically binds to HSA and provides 14 FL signal, there are no interfering peak, resulting in highly selective determination. The proposed 15 method was successfully applied for determination of HMA and HNA1 in serum of healthy donors 16 and DM patients. This method will be a useful technique to observe the redox state of HSA. The authors thank Ms. Marwa Fathy Bakr Ali for her assisting in preparation of this paper. 
